Literature DB >> 17679612

Quantitative measures of electrocardiographic left ventricular mass, conduction, and repolarization, and long-term survival after coronary artery bypass grafting.

Michael S Lauer1, Derlis Martino, Hemant Ishwaran, Eugene H Blackstone.   

Abstract

BACKGROUND: Quantitative ECG measures of left ventricular mass and repolarization predict outcome in population-based cohorts and patients with hypertension. We assessed the prognostic value of preoperative quantitative electrocardiography in patients who underwent isolated coronary artery bypass grafting. METHODS AND
RESULTS: For 6 years we followed 8166 patients who underwent primary isolated coronary artery bypass grafting between 1990 and 2003, all of whom had routine preoperative ECGs. With use of specialized digital software, quantitative measures were recorded on ventricular rate, P duration, PR interval, QRS duration, QT interval, QRS axis, Sokolow-Lyon and Cornell voltages, and ST-segment depression and slope. There were 1516 deaths. After adjustment for age, gender, clinical characteristics, left ventricular ejection fraction, and other confounders, death was independently predicted by ventricular rate (adjusted hazard ratio [AHR] for 90 versus 60 beats per minute, 1.34; 95% confidence interval [CI], 1.21 to 1.50; P<.0001), PR interval (AHR for 200 versus 150 ms, 1.05; 95% CI, 1.00 to 1.10; P<.0001), QRS duration (AHR for 120 versus 80 ms, 1.24; 95% CI, 1.07 to 1.44; P<.0001), Sokolow-Lyon voltage (AHR for 3.5 versus 1.5 mV, 1.18; 95% CI, 1.05 to 1.31; P<.0001), and ST-segment slope (AHR for -0.1 versus 0 mV, 1.16; 95% CI, 1.02 to 1.31; P<.0001). We derived a quantitative ECG score and demonstrated that, with the exception of age, it was the most powerful predictor of long-term death.
CONCLUSIONS: Quantitative ECG measures of left ventricular rate, mass, and repolarization are predictive of mortality among patients who underwent isolated coronary artery bypass grafting. These findings suggest that quantitative electrocardiography may be valuable for risk stratification in patients with severe coronary artery disease.

Entities:  

Mesh:

Year:  2007        PMID: 17679612     DOI: 10.1161/CIRCULATIONAHA.107.698019

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  The year of 2007 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-07       Impact factor: 1.468

2.  Quantitative electrocardiographic measures, neuromuscular disorders, and survival in left ventricular hypertrabeculation/noncompaction.

Authors:  Claudia Stöllberger; Daniel Gerger; Christian Wegner; Josef Finsterer
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-05       Impact factor: 1.468

Review 3.  P wave indices: current status and future directions in epidemiology, clinical, and research applications.

Authors:  Jared W Magnani; Mary Ann Williamson; Patrick T Ellinor; Kevin M Monahan; Emelia J Benjamin
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02

4.  Quantitative electrocardiographic measures and long-term mortality in exercise test patients with clinically normal resting electrocardiograms.

Authors:  Eiran Z Gorodeski; Hemant Ishwaran; Eugene H Blackstone; Michael S Lauer
Journal:  Am Heart J       Date:  2009-07       Impact factor: 4.749

5.  Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction.

Authors:  Eileen Hsich; Eiran Z Gorodeski; Randall C Starling; Eugene H Blackstone; Hemant Ishwaran; Michael S Lauer
Journal:  Circulation       Date:  2009-06-15       Impact factor: 29.690

6.  P-wave duration is a predictor for long-term mortality in post-CABG patients.

Authors:  Sheila Tatsumi Kimura-Medorima; Ana Paula Beppler Lazaro Lino; Marcel P C Almeida; Marcio J O Figueiredo; Lindemberg da Mota Silveira-Filho; Pedro Paulo Martins de Oliveira; Otavio Rizzi Coelho; José Roberto Matos Souza; Wilson Nadruz; Orlando Petrucci; Andrei C Sposito
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.